|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
35,915,000 |
Market
Cap: |
4.57(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$36.74 - $124.44 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile TransMedics Group is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across various disease states. Co. has developed the Organ Care System (OCS), a portable organ perfusion and monitoring system that using Co.'s technology to replicate near-physiologic conditions for donor organs outside of the human body. The OCS was designed to perfuse donor organs with warm, oxygenated and nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. Co.'s OCS products are one for each of lung, heart and liver transplantations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
2,500 |
2,500 |
Total Buy Value |
$0 |
$0 |
$155,000 |
$155,000 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
271,054 |
342,899 |
405,806 |
1,060,395 |
Total Sell Value |
$27,491,657 |
$33,196,965 |
$37,923,912 |
$74,654,923 |
Total People Sold |
4 |
6 |
6 |
10 |
Total Sell Transactions |
21 |
30 |
40 |
119 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Khayal Tamer I |
Chief Commercial Officer |
|
2022-08-24 |
4 |
OE |
$2.21 |
$4,367 |
D/D |
1,976 |
3,276 |
|
- |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2022-08-24 |
4 |
AS |
$50.18 |
$126,153 |
I/I |
(2,514) |
24,776 |
|
4% |
|
Hassanein Waleed H |
President & CEO |
|
2022-08-24 |
4 |
AS |
$50.13 |
$180,017 |
D/D |
(3,591) |
466,285 |
|
4% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2022-08-23 |
4 |
AS |
$50.04 |
$374,599 |
I/I |
(7,486) |
27,290 |
|
9% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2022-08-23 |
4 |
AS |
$50.04 |
$401,521 |
D/D |
(8,024) |
1,300 |
|
9% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2022-08-23 |
4 |
OE |
$2.21 |
$17,733 |
D/D |
8,024 |
9,324 |
|
- |
|
Hassanein Waleed H |
President & CEO |
|
2022-08-23 |
4 |
AS |
$50.04 |
$821,106 |
D/D |
(16,409) |
469,876 |
|
9% |
|
Hassanein Waleed H |
President & CEO |
|
2022-08-12 |
4 |
S |
$48.00 |
$336,000 |
D/D |
(7,000) |
486,285 |
|
-27% |
|
Hassanein Waleed H |
President & CEO |
|
2022-08-11 |
4 |
S |
$46.74 |
$604,301 |
D/D |
(12,929) |
493,285 |
|
-28% |
|
Gordon Stephen |
Chief Financial Officer |
|
2022-08-08 |
4 |
AS |
$48.09 |
$480,900 |
D/D |
(10,000) |
5,714 |
|
20% |
|
Gordon Stephen |
Chief Financial Officer |
|
2022-08-08 |
4 |
OE |
$2.21 |
$22,100 |
D/D |
10,000 |
15,714 |
|
- |
|
Hassanein Waleed H |
President & CEO |
|
2022-08-05 |
4 |
AS |
$45.13 |
$902,600 |
D/D |
(20,000) |
506,214 |
|
22% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2022-08-05 |
4 |
AS |
$45.08 |
$450,800 |
I/I |
(10,000) |
34,776 |
|
22% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2022-08-05 |
4 |
AS |
$45.16 |
$451,600 |
D/D |
(10,000) |
1,300 |
|
22% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2022-08-05 |
4 |
OE |
$2.21 |
$22,100 |
D/D |
10,000 |
11,300 |
|
- |
|
Carey John F |
VP of Operations |
|
2022-08-01 |
4 |
AS |
$40.02 |
$123,802 |
D/D |
(3,000) |
771 |
|
43% |
|
Carey John F |
VP of Operations |
|
2022-08-01 |
4 |
OE |
$2.21 |
$6,630 |
D/D |
3,000 |
3,771 |
|
- |
|
Tobin James R |
Director |
|
2022-07-29 |
4 |
AS |
$39.98 |
$1,939,630 |
I/I |
(48,515) |
253,591 |
|
46% |
|
Carey John F |
VP of Operations |
|
2022-07-29 |
4 |
AS |
$40.01 |
$160,040 |
D/D |
(4,000) |
771 |
|
46% |
|
Carey John F |
VP of Operations |
|
2022-07-29 |
4 |
OE |
$2.21 |
$31,434 |
D/D |
4,000 |
4,771 |
|
- |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2022-07-29 |
4 |
AS |
$40.01 |
$540,295 |
D/D |
(13,504) |
46,076 |
|
46% |
|
Khayal Tamer I |
Chief Commercial Officer |
|
2022-07-29 |
4 |
OE |
$0.28 |
$18,880 |
D/D |
13,504 |
59,580 |
|
- |
|
Carey John F |
VP of Operations |
|
2022-07-20 |
4 |
AS |
$34.57 |
$51,855 |
D/D |
(1,500) |
379 |
|
77% |
|
Carey John F |
VP of Operations |
|
2022-07-20 |
4 |
OE |
$13.28 |
$20,993 |
D/D |
1,500 |
1,879 |
|
- |
|
Carey John F |
VP of Operations |
|
2022-07-11 |
4 |
AS |
$32.98 |
$49,470 |
D/D |
(1,500) |
379 |
|
67% |
|
350 Records found
|
|
Page 8 of 14 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|